Proton monoenergetic arc therapy (PMAT) to enhance LETd within the target.


Journal

Physics in medicine and biology
ISSN: 1361-6560
Titre abrégé: Phys Med Biol
Pays: England
ID NLM: 0401220

Informations de publication

Date de publication:
19 08 2020
Historique:
pubmed: 20 5 2020
medline: 11 11 2020
entrez: 20 5 2020
Statut: epublish

Résumé

We show the performance and feasibility of a proton arc technique so-called proton monoenergetic arc therapy (PMAT). Monoenergetic partial arcs are selected to place spots at the middle of a target and its potential to enhance the dose-averaged linear energy transfer (LETd) distribution within the target. Single-energy partial arcs in a single 360 degree gantry rotation are selected to deposit Bragg's peaks at the central part of the target to increase LETd values. An in-house inverse planning optimizer seeks for homogeneous doses at the target while keeping the dose to organs at risk (OARs) within constraints. The optimization consists of balancing the weights of spots coming out of selected partial arcs. A simple case of a cylindrical target in a phantom is shown to illustrate the method. Three different brain cancer cases are then considered to produce actual clinical plans, compared to those clinically used with pencil beam scanning (PBS). The relative biological effectiveness (RBE) is calculated according to the microdosimetric kinetic model (MKM). For the ideal case of a cylindrical target placed in a cylindrical phantom, the mean LETd in the target increases from 2.8 keV μm

Identifiants

pubmed: 32428896
doi: 10.1088/1361-6560/ab9455
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

165006

Auteurs

A Bertolet (A)

Department of Radiation Oncology, Hospital of The University of Pennsylvania, Philadelphia 19104, PA, United States of America.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH